SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-079287
Filing Date
2024-07-01
Accepted
2024-07-01 09:00:58
Documents
16
Period of Report
2024-07-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sclx-20240701.htm   iXBRL 8-K 46004
2 EX-99.1 sclx-ex99_1.htm EX-99.1 34186
3 GRAPHIC img191798281_0.jpg GRAPHIC 14272
4 GRAPHIC img191798281_1.jpg GRAPHIC 8177
5 GRAPHIC img191798281_2.jpg GRAPHIC 11277
6 GRAPHIC img191798281_3.jpg GRAPHIC 17053
  Complete submission text file 0000950170-24-079287.txt   316897

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20240701.xsd EX-101.SCH 55758
18 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20240701_htm.xml XML 6489
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241088406
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)